Literature DB >> 21859137

Evaluation of the synthesis of sialic acid-PAMAM glycodendrimers without the use of sugar protecting groups, and the anti-HIV-1 properties of these compounds.

Russell Clayton1, Janee Hardman, Celia C LaBranche, Katherine D McReynolds.   

Abstract

A study was undertaken to evaluate the feasibility of synthesizing six sialic acid-PAMAM glycodendrimers using unprotected sialic acid in as few as 1-4 steps using two different reaction pathways, and to assess the sulfated derivatives for anti-HIV activity. The syntheses were accomplished through either the direct attachment of the sialic acid carboxyl group to amine-terminated PAMAM (a divergent-like approach) using BOP coupling, or by first reacting sialic acid with a polar bifunctional spacer molecule, attaching the sugar-linker to carboxy-terminated PAMAM (a convergent-like approach), and again using BOP-mediated coupling reactions. It was hypothesized that the latter approach would be the most successful method, as any steric congestion between the sialic acid and the PAMAM would be minimized using an intervening polar linker. However, the divergent-like synthesis proved to be the superior method, resulting in 11.4%, 14%, and 28% of the fully substituted generations 0, 1, and 2 sialic acid-PAMAM conjugates, respectively, as compared to 6.4% of only the generation -0.5 sialic acid-linker-PAMAM conjugate for the convergent-like method. Upon sulfation of the four glycodendrimers, binding capabilities to the recombinant HIV protein, gp120, were assessed using an ELISA assay. Compounds that showed promising binding characteristics were then further assessed for inhibition of HIV-1 infection using a well-characterized luciferase reporter gene neutralization assay. The generation 2 sulfated sialic acid-PAMAM glycodendrimer, sulfo-6, bearing 16 sialic acids with 11 sulfate groups incorporated at 4.03% sulfur content by weight, was found to inhibit all four HIV-1 strains tested in the low micromolar range.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21859137      PMCID: PMC3241508          DOI: 10.1021/bc200331v

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  41 in total

1.  Synthesis of sulfated colominic acids and their interaction with fibroblast growth factors.

Authors:  M Kunou; M Koizumi; K Shimizu; M Kawase; K Hatanaka
Journal:  Biomacromolecules       Date:  2000       Impact factor: 6.988

2.  Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro.

Authors:  M Ito; M Baba; A Sato; R Pauwels; E De Clercq; S Shigeta
Journal:  Antiviral Res       Date:  1987-07       Impact factor: 5.970

3.  Dextran sulfate is poorly absorbed after oral administration.

Authors:  K J Lorentsen; C W Hendrix; J M Collins; D M Kornhauser; B G Petty; R W Klecker; C Flexner; R H Eckel; P S Lietman
Journal:  Ann Intern Med       Date:  1989-10-01       Impact factor: 25.391

Review 4.  Chemical glycobiology.

Authors:  C R Bertozzi; L L Kiessling
Journal:  Science       Date:  2001-03-23       Impact factor: 47.728

5.  Antibody neutralization and escape by HIV-1.

Authors:  Xiping Wei; Julie M Decker; Shuyi Wang; Huxiong Hui; John C Kappes; Xiaoyun Wu; Jesus F Salazar-Gonzalez; Maria G Salazar; J Michael Kilby; Michael S Saag; Natalia L Komarova; Martin A Nowak; Beatrice H Hahn; Peter D Kwong; George M Shaw
Journal:  Nature       Date:  2003-03-20       Impact factor: 49.962

6.  Novel polysulfated galactose-derivatized dendrimers as binding antagonists of human immunodeficiency virus type 1 infection.

Authors:  Richard D Kensinger; Bradley J Catalone; Fred C Krebs; Brian Wigdahl; Cara-Lynne Schengrund
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

7.  The influence of surface modification on the cytotoxicity of PAMAM dendrimers.

Authors:  R Jevprasesphant; J Penny; R Jalal; D Attwood; N B McKeown; A D'Emanuele
Journal:  Int J Pharm       Date:  2003-02-18       Impact factor: 5.875

8.  Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro.

Authors:  M Baba; R Pauwels; J Balzarini; J Arnout; J Desmyter; E De Clercq
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

9.  Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells.

Authors:  H Mitsuya; D J Looney; S Kuno; R Ueno; F Wong-Staal; S Broder
Journal:  Science       Date:  1988-04-29       Impact factor: 47.728

10.  Synthesis of novel, multivalent glycodendrimers as ligands for HIV-1 gp120.

Authors:  Richard D Kensinger; Brian C Yowler; Alan J Benesi; Cara-Lynne Schengrund
Journal:  Bioconjug Chem       Date:  2004 Mar-Apr       Impact factor: 4.774

View more
  10 in total

Review 1.  A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.

Authors:  Abhijit A Date; Christopher J Destache
Journal:  Biomaterials       Date:  2013-05-28       Impact factor: 12.479

2.  Peptide- and saccharide-conjugated dendrimers for targeted drug delivery: a concise review.

Authors:  Jie Liu; Warren D Gray; Michael E Davis; Ying Luo
Journal:  Interface Focus       Date:  2012-03-21       Impact factor: 3.906

3.  Synthesis of Hydrophilic Aminooxy Linkers and Multivalent Cores for Chemoselective Aldehyde/Ketone Conjugation.

Authors:  Katherine D McReynolds; Dustin Dimas; Hoang Le
Journal:  Tetrahedron Lett       Date:  2014-04-02       Impact factor: 2.415

Review 4.  Polymeric drugs: Advances in the development of pharmacologically active polymers.

Authors:  Jing Li; Fei Yu; Yi Chen; David Oupický
Journal:  J Control Release       Date:  2015-09-26       Impact factor: 9.776

Review 5.  Nanotechnology and the treatment of HIV infection.

Authors:  Raveen Parboosing; Glenn E M Maguire; Patrick Govender; Hendrik G Kruger
Journal:  Viruses       Date:  2012-04-10       Impact factor: 5.048

Review 6.  Baseline and time-updated factors in preclinical development of anionic dendrimers as successful anti-HIV-1 vaginal microbicides.

Authors:  Ignacio Rodríguez-Izquierdo; Daniel Sepúlveda-Crespo; Jose María Lasso; Salvador Resino; Ma Ángeles Muñoz-Fernández
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2022-01-12

Review 7.  Multivalent Sialosides: A Tool to Explore the Role of Sialic Acids in Biological Processes.

Authors:  Preeti Madhukar Chaudhary; Suraj Toraskar; Rohan Yadav; Akshay Hande; Rina-Arad Yellin; Raghavendra Kikkeri
Journal:  Chem Asian J       Date:  2019-04-10

Review 8.  Peptides and Dendrimers: How to Combat Viral and Bacterial Infections.

Authors:  Annarita Falanga; Valentina Del Genio; Stefania Galdiero
Journal:  Pharmaceutics       Date:  2021-01-14       Impact factor: 6.321

9.  Sulfoglycodendrimer Therapeutics for HIV-1 and SARS-CoV-2.

Authors:  Lauren Wells; Cory Vierra; Janee' Hardman; Yanxiao Han; Dustin Dimas; Lucia N Gwarada-Phillips; Rachel Blackeye; Daryl K Eggers; Celia C LaBranche; Petr Král; Katherine D McReynolds
Journal:  Adv Ther (Weinh)       Date:  2021-02-12

10.  Ramified derivatives of 5-(perylen-3-ylethynyl)uracil-1-acetic acid and their antiviral properties.

Authors:  Ksenia A Sapozhnikova; Nikita A Slesarchuk; Alexey A Orlov; Evgeny V Khvatov; Eugene V Radchenko; Alexey A Chistov; Alexey V Ustinov; Vladimir A Palyulin; Liubov I Kozlovskaya; Dmitry I Osolodkin; Vladimir A Korshun; Vladimir A Brylev
Journal:  RSC Adv       Date:  2019-08-20       Impact factor: 4.036

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.